Shared Decision Making and Multidisciplinary Collaboration in the Evolving HR+/HER2- Early-Stage Breast Cancer Landscape

Hope Rugo, MD, FASCO, and Naomi Dempsey, MD, emphasize the importance of shared decision-making, comprehensive data, and well-informed multidisciplinary team collaboration in delivering high-quality, patient-centered care, while highlighting the benefits of tailored adjuvant therapies.

Related Keywords

,Optimizing Patient Outcomes ,Stage Breast Cancer ,Decision Making ,Multidisciplinary Collaboration ,Stage Breast Cancer Landscape ,Shared Decision Making ,Toxicity ,Benefits ,Dose Reduction ,Treatment Holiday ,Adjuvant Radiation ,Endocrine Therapy ,Neoadjuvant Endocrine Therapy ,Biomarkers ,Neoadjuvant Trials ,Abemaciclib ,